 Sarkis Derderian
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 5 | 2020 | 197 | 2.390 |
Why?
| | Bariatric Surgery | 4 | 2020 | 161 | 2.320 |
Why?
| | Fetal Therapies | 7 | 2015 | 30 | 1.740 |
Why?
| | Hernias, Diaphragmatic, Congenital | 6 | 2023 | 186 | 1.710 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 2 | 2023 | 5 | 1.370 |
Why?
| | Myasthenia Gravis | 2 | 2020 | 18 | 1.370 |
Why?
| | Body Contouring | 2 | 2020 | 8 | 1.360 |
Why?
| | Fetal Diseases | 4 | 2018 | 147 | 1.080 |
Why?
| | Respiratory System Abnormalities | 2 | 2023 | 12 | 1.010 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2023 | 9 | 0.890 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 17 | 0.880 |
Why?
| | Transplantation Conditioning | 2 | 2014 | 151 | 0.870 |
Why?
| | Retrospective Studies | 25 | 2023 | 12550 | 0.830 |
Why?
| | Catheterization, Central Venous | 2 | 2023 | 83 | 0.790 |
Why?
| | Specialties, Surgical | 2 | 2022 | 70 | 0.790 |
Why?
| | Wounds, Nonpenetrating | 2 | 2022 | 256 | 0.770 |
Why?
| | Weight Loss | 3 | 2020 | 642 | 0.770 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2018 | 520 | 0.750 |
Why?
| | Empyema | 1 | 2021 | 4 | 0.740 |
Why?
| | Chest Tubes | 2 | 2023 | 30 | 0.730 |
Why?
| | Thymectomy | 1 | 2019 | 15 | 0.680 |
Why?
| | Empyema, Pleural | 1 | 2019 | 11 | 0.680 |
Why?
| | Colonic Pouches | 1 | 2019 | 14 | 0.670 |
Why?
| | Trauma Centers | 1 | 2022 | 362 | 0.660 |
Why?
| | Laparoscopy | 2 | 2020 | 398 | 0.660 |
Why?
| | Thoracoscopy | 1 | 2019 | 57 | 0.660 |
Why?
| | Spinal Injuries | 1 | 2019 | 47 | 0.640 |
Why?
| | Colectomy | 1 | 2019 | 86 | 0.640 |
Why?
| | Pregnancy | 15 | 2023 | 5518 | 0.620 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 105 | 0.610 |
Why?
| | Forecasting | 1 | 2019 | 330 | 0.600 |
Why?
| | Ultrasonography, Prenatal | 6 | 2023 | 236 | 0.590 |
Why?
| | Sacrococcygeal Region | 1 | 2017 | 5 | 0.590 |
Why?
| | Amniotic Band Syndrome | 2 | 2014 | 4 | 0.580 |
Why?
| | Hematopoietic Stem Cells | 3 | 2016 | 343 | 0.580 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 234 | 0.570 |
Why?
| | Fetoscopy | 2 | 2014 | 28 | 0.570 |
Why?
| | Bacteremia | 1 | 2018 | 160 | 0.550 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.540 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 227 | 0.530 |
Why?
| | Thrombosis | 1 | 2018 | 298 | 0.500 |
Why?
| | Humans | 43 | 2023 | 114686 | 0.500 |
Why?
| | Surgeons | 1 | 2019 | 239 | 0.490 |
Why?
| | Hydrops Fetalis | 1 | 2014 | 13 | 0.480 |
Why?
| | Betamethasone | 1 | 2014 | 19 | 0.470 |
Why?
| | Fetal Stem Cells | 1 | 2014 | 7 | 0.470 |
Why?
| | Hydrothorax | 1 | 2014 | 3 | 0.460 |
Why?
| | Adolescent | 12 | 2023 | 17844 | 0.460 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1167 | 0.450 |
Why?
| | Child | 14 | 2023 | 18414 | 0.450 |
Why?
| | Critical Illness | 1 | 2018 | 646 | 0.440 |
Why?
| | Magnetic Resonance Imaging | 3 | 2023 | 3052 | 0.440 |
Why?
| | Pediatric Obesity | 1 | 2020 | 488 | 0.430 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2017 | 858 | 0.400 |
Why?
| | Female | 24 | 2023 | 59507 | 0.390 |
Why?
| | Pediatrics | 1 | 2019 | 980 | 0.380 |
Why?
| | Central Venous Catheters | 2 | 2023 | 40 | 0.370 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2286 | 0.350 |
Why?
| | Pulmonary Artery | 1 | 2015 | 1016 | 0.340 |
Why?
| | Infant, Newborn | 11 | 2023 | 5047 | 0.330 |
Why?
| | Placenta | 1 | 2014 | 626 | 0.320 |
Why?
| | Antibodies, Monoclonal | 1 | 2014 | 1262 | 0.310 |
Why?
| | Obesity | 1 | 2020 | 2508 | 0.310 |
Why?
| | Fetus | 3 | 2023 | 700 | 0.290 |
Why?
| | Pregnancy Outcome | 3 | 2014 | 337 | 0.290 |
Why?
| | Lung Volume Measurements | 2 | 2023 | 45 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-kit | 3 | 2018 | 63 | 0.270 |
Why?
| | Morbidity | 2 | 2023 | 280 | 0.260 |
Why?
| | Gestational Age | 4 | 2021 | 760 | 0.250 |
Why?
| | Length of Stay | 2 | 2019 | 962 | 0.250 |
Why?
| | Liver | 4 | 2023 | 1637 | 0.240 |
Why?
| | Prospective Studies | 3 | 2020 | 6220 | 0.240 |
Why?
| | California | 2 | 2017 | 353 | 0.240 |
Why?
| | Follow-Up Studies | 3 | 2019 | 4411 | 0.230 |
Why?
| | Ostomy | 1 | 2023 | 3 | 0.230 |
Why?
| | Male | 12 | 2023 | 55596 | 0.220 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 28 | 0.220 |
Why?
| | Lung | 4 | 2023 | 3561 | 0.220 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2023 | 40 | 0.220 |
Why?
| | Thoracotomy | 2 | 2023 | 75 | 0.220 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 62 | 0.210 |
Why?
| | Survival Rate | 3 | 2017 | 1644 | 0.210 |
Why?
| | Steroids | 1 | 2023 | 144 | 0.210 |
Why?
| | Gastrectomy | 2 | 2020 | 82 | 0.210 |
Why?
| | Pneumothorax | 1 | 2023 | 42 | 0.210 |
Why?
| | Infant | 6 | 2023 | 7963 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 19 | 0.200 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 104 | 0.200 |
Why?
| | Meningomyelocele | 1 | 2022 | 55 | 0.200 |
Why?
| | Hydrocephalus | 1 | 2022 | 83 | 0.190 |
Why?
| | Funnel Chest | 1 | 2021 | 22 | 0.190 |
Why?
| | Analgesia, Epidural | 1 | 2021 | 20 | 0.190 |
Why?
| | Young Adult | 6 | 2023 | 10469 | 0.190 |
Why?
| | Drainage | 2 | 2019 | 151 | 0.190 |
Why?
| | Nerve Block | 1 | 2021 | 60 | 0.180 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 241 | 0.180 |
Why?
| | Laryngeal Diseases | 1 | 2021 | 21 | 0.180 |
Why?
| | Adult | 9 | 2022 | 30550 | 0.180 |
Why?
| | Wound Closure Techniques | 1 | 2020 | 9 | 0.180 |
Why?
| | Appendix | 1 | 2020 | 27 | 0.170 |
Why?
| | Proctocolectomy, Restorative | 1 | 2019 | 19 | 0.170 |
Why?
| | Abdominoplasty | 1 | 2019 | 6 | 0.170 |
Why?
| | Injury Severity Score | 1 | 2022 | 499 | 0.170 |
Why?
| | Tracheostomy | 1 | 2021 | 101 | 0.170 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 19 | 0.170 |
Why?
| | Odds Ratio | 1 | 2022 | 953 | 0.160 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 84 | 0.160 |
Why?
| | Cell Lineage | 2 | 2018 | 309 | 0.160 |
Why?
| | Appendicitis | 1 | 2020 | 114 | 0.160 |
Why?
| | Airway Obstruction | 1 | 2021 | 168 | 0.160 |
Why?
| | Tranexamic Acid | 1 | 2018 | 39 | 0.150 |
Why?
| | Job Satisfaction | 1 | 2019 | 168 | 0.140 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 181 | 0.140 |
Why?
| | Maternal-Fetal Exchange | 2 | 2014 | 151 | 0.130 |
Why?
| | Incidence | 3 | 2017 | 2313 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2022 | 671 | 0.130 |
Why?
| | Seizures | 1 | 2018 | 340 | 0.130 |
Why?
| | Graft Survival | 1 | 2018 | 446 | 0.120 |
Why?
| | Ultrasonography, Doppler | 1 | 2015 | 105 | 0.120 |
Why?
| | Mice, Inbred C57BL | 2 | 2014 | 4694 | 0.120 |
Why?
| | Child, Preschool | 2 | 2019 | 9116 | 0.120 |
Why?
| | Cholelithiasis | 1 | 2014 | 31 | 0.120 |
Why?
| | Treatment Outcome | 4 | 2023 | 9088 | 0.120 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2014 | 2 | 0.120 |
Why?
| | Biliary Tract Diseases | 1 | 2014 | 32 | 0.120 |
Why?
| | Injections | 1 | 2014 | 159 | 0.110 |
Why?
| | Injections, Intramuscular | 1 | 2014 | 116 | 0.110 |
Why?
| | Vascular Remodeling | 1 | 2015 | 153 | 0.110 |
Why?
| | Stem Cell Niche | 1 | 2014 | 42 | 0.110 |
Why?
| | Fetal Development | 1 | 2016 | 246 | 0.110 |
Why?
| | Jaundice, Neonatal | 1 | 2013 | 8 | 0.110 |
Why?
| | Carbolines | 1 | 2013 | 27 | 0.110 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 36 | 0.110 |
Why?
| | Bone Marrow | 1 | 2014 | 243 | 0.110 |
Why?
| | Echocardiography | 1 | 2015 | 553 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 184 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 926 | 0.100 |
Why?
| | Mice | 4 | 2018 | 14869 | 0.100 |
Why?
| | Prognosis | 2 | 2022 | 3329 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2014 | 778 | 0.100 |
Why?
| | Risk Factors | 3 | 2022 | 8632 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2016 | 766 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 4623 | 0.090 |
Why?
| | Biliary Atresia | 1 | 2013 | 185 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 382 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 720 | 0.090 |
Why?
| | Graft Rejection | 1 | 2014 | 513 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1842 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2014 | 532 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2014 | 429 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1737 | 0.080 |
Why?
| | Animals | 5 | 2018 | 31706 | 0.080 |
Why?
| | Hypertension, Pulmonary | 2 | 2015 | 1729 | 0.070 |
Why?
| | Prenatal Diagnosis | 2 | 2021 | 167 | 0.070 |
Why?
| | Chimerism | 2 | 2018 | 28 | 0.070 |
Why?
| | United States | 1 | 2020 | 12183 | 0.060 |
Why?
| | Diaphragm | 1 | 2023 | 33 | 0.060 |
Why?
| | Glycerol | 1 | 2023 | 84 | 0.050 |
Why?
| | Gastrostomy | 1 | 2023 | 91 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2023 | 121 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2022 | 79 | 0.050 |
Why?
| | Glutathione | 1 | 2023 | 293 | 0.050 |
Why?
| | Evidence-Based Practice | 1 | 2023 | 185 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 473 | 0.050 |
Why?
| | Obstetric Labor Complications | 1 | 2021 | 30 | 0.050 |
Why?
| | Ultrasonography, Interventional | 1 | 2021 | 123 | 0.050 |
Why?
| | Surgical Stapling | 1 | 2020 | 9 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 253 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 935 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2021 | 191 | 0.040 |
Why?
| | Stomach | 1 | 2020 | 102 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 115 | 0.040 |
Why?
| | Cesarean Section | 1 | 2021 | 169 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 326 | 0.040 |
Why?
| | Curriculum | 1 | 2023 | 819 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 314 | 0.030 |
Why?
| | Polymers | 1 | 2020 | 448 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 344 | 0.030 |
Why?
| | Fetal Blood | 1 | 2018 | 270 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 78 | 0.030 |
Why?
| | Antibodies | 1 | 2018 | 371 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 296 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 152 | 0.030 |
Why?
| | San Francisco | 1 | 2015 | 54 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 371 | 0.030 |
Why?
| | Perinatal Death | 1 | 2014 | 22 | 0.030 |
Why?
| | Biliary Fistula | 1 | 2014 | 3 | 0.030 |
Why?
| | Rupture, Spontaneous | 1 | 2014 | 16 | 0.030 |
Why?
| | Fetal Death | 1 | 2014 | 50 | 0.030 |
Why?
| | Watchful Waiting | 1 | 2015 | 55 | 0.030 |
Why?
| | Cholecystectomy | 1 | 2014 | 45 | 0.030 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2014 | 21 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 385 | 0.030 |
Why?
| | Tadalafil | 1 | 2013 | 7 | 0.030 |
Why?
| | Portal Vein | 1 | 2014 | 76 | 0.030 |
Why?
| | Second Messenger Systems | 1 | 2013 | 32 | 0.030 |
Why?
| | Aneuploidy | 1 | 2014 | 85 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2013 | 84 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2013 | 80 | 0.030 |
Why?
| | Georgia | 1 | 2013 | 62 | 0.030 |
Why?
| | Hernia, Diaphragmatic | 1 | 2013 | 67 | 0.030 |
Why?
| | Abortion, Induced | 1 | 2014 | 71 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2013 | 161 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2013 | 141 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2014 | 140 | 0.030 |
Why?
| | Random Allocation | 1 | 2013 | 335 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 436 | 0.030 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2014 | 203 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2014 | 323 | 0.020 |
Why?
| | Cholestasis | 1 | 2014 | 225 | 0.020 |
Why?
| | Sheep | 1 | 2013 | 764 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2018 | 1701 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2013 | 480 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1342 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3535 | 0.010 |
Why?
|
|
Derderian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|